Clopidogrel On Top of Aspirin For the Prevention of New Onset Migraine Headache Occurrence Following Transcatheter Closure of Atrial Septal Defects: A Prospective Randomized Trial (the CANOA Study)

Trial Profile

Clopidogrel On Top of Aspirin For the Prevention of New Onset Migraine Headache Occurrence Following Transcatheter Closure of Atrial Septal Defects: A Prospective Randomized Trial (the CANOA Study)

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 May 2017

At a glance

  • Drugs Clopidogrel (Primary) ; Aspirin
  • Indications Embolism and thrombosis; Migraine
  • Focus Therapeutic Use
  • Acronyms CANOA
  • Most Recent Events

    • 09 Nov 2015 Primary endpoint has been met. (Mean number of monthly migraine days per patient within the 3 months following transcatheter ASD closure.)
    • 09 Nov 2015 Results published in the JAMA: the Journal of the American Medical Association
    • 09 Nov 2015 Status changed from active, no longer recruiting to completed, according to results published in JAMA.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top